Neoleukin: Neoleukin: Q3 Earnings Snapshot

SEATTLE - SEATTLE - Neoleukin Therapeutics, Inc. on Tuesday reported a loss of $4.5 million in its third quarter. On a per-share basis, the Seattle-based company said it had a loss of 41... SEATTLE (AP) - SEATTLE (AP) - Neoleukin Therapeutics, Inc. (NLTX) on Tuesday reported a loss of $4.5 million in its third quarter. On a per-share basis, the Seattle -based company said it had a loss of 41 cents . _____ This story was generated by Automated Insights ( http://automatedinsights.com/ap) using data from Zacks Investment Research . Access a Zacks stock report on NLTX at https://www.zacks.com/ap/NLTX For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News